This possibility is indirectly supported by the observation that higher FGF-23 levels are associated with vascular calcification, endothelial dysfunction and left ventricular hypertrophy in CKD patients [15], [37], [38]. The gene discussed is FGF23; the disease is left ventricular hypertrophy.